Accordingly, we found that the CD68/CD206/Gal-3+ M2 macrophage number was reduced in patients with steatosis and NASH with a high grade of portal inflammation, or ballooning. The gene discussed is CD68; the disease is metabolic dysfunction-associated steatohepatitis.